Andhra Pradesh, India

Vishnubhotla Nagaprasad


Average Co-Inventor Count = 2.9

ph-index = 2

Forward Citations = 15(Granted Patents)


Location History:

  • Warangal, IN (2000)
  • Andhra Pradesh, IN (2006 - 2014)
  • Hyderabad, IN (2014)

Company Filing History:


Years Active: 2000-2014

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Vishnubhotla Nagaprasad: Innovator in Gastrointestinal Treatments

Introduction

Vishnubhotla Nagaprasad is a notable inventor based in Andhra Pradesh, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stable oral compositions for treating gastrointestinal disorders. With a total of 4 patents to his name, his work has the potential to impact many lives.

Latest Patents

One of his latest patents is titled "Stable oral benzimidazole compositions and process of preparation thereof." This invention relates to stable oral compositions of one or more benzimidazole compounds and outlines processes for their preparation. Additionally, it provides methods for treating various gastrointestinal disorders, showcasing his commitment to improving health outcomes.

Career Highlights

Vishnubhotla Nagaprasad is currently associated with Ranbaxy Laboratories, Inc., a prominent player in the pharmaceutical industry. His role at the company allows him to leverage his expertise in drug formulation and development, contributing to innovative solutions in healthcare.

Collaborations

Throughout his career, Vishnubhotla has collaborated with talented professionals, including Rajesh Gandhi and Chayapathy Issa. These collaborations have likely enriched his work and fostered a creative environment for innovation.

Conclusion

Vishnubhotla Nagaprasad stands out as an influential inventor in the pharmaceutical sector, particularly in the area of gastrointestinal treatments. His patents reflect a dedication to advancing medical science and improving patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…